Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Conjugate Vaccines Market to reach USD XXX billion by the end of 2029

Global Conjugate Vaccines Market Size study & Forecast, by Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines) by Disease Indication (Pneumococcal, Influenza, Diphtheria Tetanus and Pertussis (DTP), Meningococcal, Others), by Pathogen Type (Bacterial Conjugate Vaccine, Viral Conjugate Vaccine, Combination (Viral and Bacterial) Conjugate Vaccine), by End User (Pediatrics, Adults) and Regional Analysis, 2022-2029

Product Code: HLSDT-69336756
Publish Date: 8-02-2023
Page: 200

Global Conjugate Vaccines Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. A conjugate vaccine is a kind of subunit vaccine that uses a strong antigen as a carrier to combine a weak antigen with, thus enhancing the immune system’s response to the weak antigen. By enhancing an immune response to an antigen, vaccines are used to avoid diseases like Haemophilus influenzae B (Hib), pneumococcus and others. The key factor driving the market growth of conjugate vaccines is rising government approvals and prevalence of pneumococcal disease globally. Thus, create the lucrative demand for the market during forecast period.

The Conjugate Vaccines is widely used to avoid pneumococcus diseases. Thus, the increasing prevalence of pneumococcus diseases is anticipated to propelling demand for the market during forecast period. According to WHO, 7,40,180 children under the age of five died from pneumonia in 2019, accounting for 14% of all child deaths in that age group but 22% of all pediatric deaths in children from 1 to 5. Children and families worldwide are affected by pneumonia, but South Asia and sub-Saharan Africa have the highest death rates. Also, the rising government approval for Conjugate Vaccines to control the rising prevalence of various types of disease and encouraging market players for introducing a new product. For instance, in April 2020, U.S. Food and Drug Administration (FDA) approved the MenQuadfi Meningococcal Conjugate Vaccine’s Biologics License Application for the treatment of invasive meningococcal disease in people two years of age and older. Also, the constant R&D activities for the development of effective vaccines would create the lucrative opportunity for the market during forecast period. However, the rising side effects associated with the conjugate vaccine stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Conjugate Vaccines Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the occurrence of the refined healthcare expenses and increasing the patient alertness level in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as presence of key market players and increasing support from the government for the vaccine development would create lucrative growth prospects for the Conjugate Vaccines market across Asia Pacific region.

Major market player included in this report are:
Novartis AG
Neuron Biotech
Serum Institute of India
Pfizer, Inc.
Sanofi Pasteur
Bharat Biotech
Biological E Ltd.
GlaxoSmithKline, plc.
Merck and Company
CSL Limited

Recent Developments in the Market:
 In June 2021, Pfizer Inc. announced that the FDA has approved PREVNAR 20TM (Pneumococcal 20-valent Conjugate Vaccine) for use in people 18 years of age and older to prevent pneumonia and invasive disease brought on by the 20 pneumococcal serotypes contained in the vaccine.
 In July 2021, Kenilworth, also known as MSD outside of the USA and Canada, announced that the U.S. Food and Drug Administration (FDA) had approved VAXNEUVANCETM (Pneumococcal 15-valent Conjugate Vaccine) (pronounced VAKS-noo-vans) for use in adults 18 years of age and older as an immunization for the prevention of invasive disease caused by streptococcus pneumoniae.
Global Conjugate Vaccines Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Disease Indication, Pathogen Type, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
By Disease Indication:
Pneumococcal
Influenza
Diphtheria Tetanus and Pertussis (DTP)
Meningococcal
Others
By Pathogen Type:
Bacterial Conjugate Vaccine
Viral Conjugate Vaccine
Combination (Viral and Bacterial) Conjugate Vaccine
By End User:
Pediatrics
Adults
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Conjugate Vaccines Market, by Region, 2019-2029 (USD Billion)
1.2.2. Conjugate Vaccines Market, by Type, 2019-2029 (USD Billion)
1.2.3. Conjugate Vaccines Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.4. Conjugate Vaccines Market, by Pathogen Type, 2019-2029 (USD Billion)
1.2.5. Conjugate Vaccines Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Conjugate Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Conjugate Vaccines Market Dynamics
3.1. Conjugate Vaccines Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Government Approvals for Conjugate Vaccines
3.1.1.2. Rising Prevalence of Pneumococcal Disease
3.1.2. Market Challenges
3.1.2.1. Rising side effects associated with the conjugate vaccine
3.1.3. Market Opportunities
3.1.3.1. Constant R&D activities for the development of effective vaccines
Chapter 4. Global Conjugate Vaccines Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Conjugate Vaccines Market, by Type
6.1. Market Snapshot
6.2. Global Conjugate Vaccines Market by Type, Performance – Potential Analysis
6.3. Global Conjugate Vaccines Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Conjugate Vaccines Market, Sub Segment Analysis
6.4.1. Monovalent Conjugate Vaccines
6.4.2. Multivalent Conjugate Vaccines
Chapter 7. Global Conjugate Vaccines Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Conjugate Vaccines Market by Disease Indication, Performance – Potential Analysis
7.3. Global Conjugate Vaccines Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
7.4. Conjugate Vaccines Market, Sub Segment Analysis
7.4.1. Pneumococcal
7.4.2. Influenza
7.4.3. Diphtheria Tetanus and Pertussis (DTP)
7.4.4. Meningococcal
7.4.5. Others
Chapter 8. Global Conjugate Vaccines Market, by Pathogen Type
8.1. Market Snapshot
8.2. Global Conjugate Vaccines Market by Pathogen Type, Performance – Potential Analysis
8.3. Global Conjugate Vaccines Market Estimates & Forecasts by Pathogen Type 2019-2029 (USD Billion)
8.4. Conjugate Vaccines Market, Sub Segment Analysis
8.4.1. Bacterial Conjugate Vaccine
8.4.2. Viral Conjugate Vaccine
8.4.3. Combination (Viral and Bacterial) Conjugate Vaccine
Chapter 9. Global Conjugate Vaccines Market, by End User
9.1. Market Snapshot
9.2. Global Conjugate Vaccines Market by End User, Performance – Potential Analysis
9.3. Global Conjugate Vaccines Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
9.4. Conjugate Vaccines Market, Sub Segment Analysis
9.4.1. Pediatrics
9.4.2. Adults
Chapter 10. Global Conjugate Vaccines Market, Regional Analysis
10.1. Conjugate Vaccines Market, Regional Market Snapshot
10.2. North America Conjugate Vaccines Market
10.2.1. U.S. Conjugate Vaccines Market
10.2.1.1. Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
10.2.1.3. Pathogen Type breakdown estimates & forecasts, 2019-2029
10.2.1.4. End User breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Conjugate Vaccines Market
10.3. Europe Conjugate Vaccines Market Snapshot
10.3.1. U.K. Conjugate Vaccines Market
10.3.2. Germany Conjugate Vaccines Market
10.3.3. France Conjugate Vaccines Market
10.3.4. Spain Conjugate Vaccines Market
10.3.5. Italy Conjugate Vaccines Market
10.3.6. Rest of Europe Conjugate Vaccines Market
10.4. Asia-Pacific Conjugate Vaccines Market Snapshot
10.4.1. China Conjugate Vaccines Market
10.4.2. India Conjugate Vaccines Market
10.4.3. Japan Conjugate Vaccines Market
10.4.4. Australia Conjugate Vaccines Market
10.4.5. South Korea Conjugate Vaccines Market
10.4.6. Rest of Asia Pacific Conjugate Vaccines Market
10.5. Latin America Conjugate Vaccines Market Snapshot
10.5.1. Brazil Conjugate Vaccines Market
10.5.2. Mexico Conjugate Vaccines Market
10.6. Rest of The World Conjugate Vaccines Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Novartis AG
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Neuron Biotech
11.2.3. Serum Institute of India
11.2.4. Pfizer, Inc.
11.2.5. Sanofi Pasteur
11.2.6. Bharat Biotech
11.2.7. Biological E Ltd.
11.2.8. GlaxoSmithKline, plc.
11.2.9. Merck and Company
11.2.10. CSL Limited
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now